Skip to main content
. 2020 Jul 2;36(7):606–615. doi: 10.1089/aid.2020.0023

Table 1.

Characteristics of Study Participants

  Age ≥50 years Age <50 years
  N = 134 N = 147
Age, years
 Mean (SD) 58 (5.4) 37 (7.9)
 Median (IQR) 56 (54–62) 37 (30–44)
Age groups, years, n (%)
 19–29 0 (0) 33 (23)
 30–39 0 (0) 52 (35)
 40–49 0 (0) 62 (42)
 50–59 90 (67) 0 (0)
 60–72 44 (33) 0 (0)
  N = 133 N = 146
Sex assigned at birth, n (%)
 Female
45 (34)
51 (35)
 Male 88 (66) 95 (65)
  N = 134 N = 147
Gender, n (%)
 
 
 Cisgender woman
48 (36)
50 (34)
 Cisgender man
85 (63)
94 (64)
 Other 1 (1) 3 (2)
  N = 133 N = 145
Race, n (%)
 
 
 White or Caucasian
98 (74)
84 (58)
 Black or African American
21 (16)
45 (31)
 Other 14 (10) 16 (11)
  N = 130 N = 141
Ethnicity, n (%)
 Hispanic or Latinx
13 (10)
19 (13)
 Not Hispanic or Latinx
112 (86)
114 (81)
 Not sure/prefer not to answer 5 (4) 8 (6)
  N = 134 N = 137
Region of residence, n (%)
 Northeast
24 (18)
18 (13)
 Midwest
18 (13)
14 (10)
 South
51 (38)
72 (53)
 West 41 (31) 33 (24)
  N = 134 N = 146
Highest level of formal education completed, n (%)
 Some high school, but no diploma
4 (3)
5 (3)
 High school diploma or GED
12 (9)
18 (12)
 Some college, but no diploma
46 (34)
38 (26)
 2- or 4-year college degree
44 (33)
49 (34)
 Master's/Professional degree/Doctorate degree or equivalent 28 (21) 36 (25)
  N = 103 N = 117
Yearly household income, n (%)
 Less than $15,000
21 (20)
20 (17)
 $15,000 to $25,000
15 (15)
13 (11)
 $25,001 to $50,000
24 (23)
32 (27)
 $50,001 to $75,000
11 (11)
13 (11)
 More than $75,000
31 (30)
30 (26)
 Prefer not to answer 1 (1) 9 (8)
  N = 103 N = 117
Marital status, n (%)
 Single or never married
33 (32)
65 (56)
 Married or living with partner
36 (35)
31 (26)
 Separated or divorced
21 (20)
17 (15)
 Widowed
10 (10)
0 (0)
 Other 3 (3) 4 (3)
  N = 133 N = 144
Ever volunteered for a study to test safety or efficacy of an ART drug or related drug, n (%)
 Yes
36 (27)
21 (15)
 No
94 (71)
121 (84)
 Don't know 3 (2) 2 (1)
  N = 133 N = 144
Ever volunteered for a medical study respondent believed to be an HIV cure study, n (%)
 Yes
20 (15)
8 (6)
 No
110 (83)
133 (92)
 Don't know 3 (2) 3 (2)
  N = 110 N = 132
Reasons why the respondents did not participate in HIV cure studies, n (%)
 Did not know about them
69 (63)
104 (79)
 Study site too far away/did not compensate for travel costs
22 (20)
18 (14)
 Did not qualify for them
20 (18)
18 (14)
 Frightened because it would stop HIV medications for some period of time
17 (15)
16 (12)
 Frightened of side effects or negative health effects
12 (11)
12 (9)
 Could not get away from work
7 (6)
9 (7)
 Required too much time away from regular routine
8 (7)
4 (3)
 Regular health provider recommended that I not participate
6 (5)
5 (4)
 Friend or family member said that I shouldn't participate
2 (2)
2 (2)
 Study did not cover childcare/family care costs involved in participation
0 (0)
1 (1)
 Other 12 (11) 10 (8)
  N = 133 N = 144
Currently in a study respondent believes to be an HIV cure study, n (%)
 Yes
3 (2)
5 (4)
 No
129 (97)
137 (95)
 Don't know 1 (1) 2 (1)

ART, antiretroviral therapy; GED, General Educational Development; IQR, interquartile range; SD, standard deviation.